Shares of Applied Optoelectronics Inc (NASDAQ:AAOI) rose sharply in pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued first-quarter sales guidance above estimates.

Applied Optoelectronics reported quarterly losses of 1 cent per share which beat the analyst consensus estimate of losses of 11 cents per share. The company reported quarterly sales of $134.274 million which beat the analyst consensus estimate of $134.120 million.

Applied Optoelectronics shares jumped 20.4% to $64.69 in the pre-market trading session.

Here are some other stocks moving in pre-market trading.

Gainers

• Veea Inc. (NASDAQ:VEEA) gained 48.1% to $0.64 in pre-market trading. Veea introduced TerraFabric at MWC 2026, enabling organizations to automate and govern AI workloads across fleets of heterogeneous edge devices at scale.
• Cardio Diagnostics Holdings Inc (NASDAQ:CDIO) gained 38.3% to $7.22 in pre-market trading.
• Ensysce Biosciences Inc (NASDAQ:ENSC) gained 28.9% to $0.51 in pre-market trading. Ensysce Biosciences recently initiated review of strategic alternatives to enhance shareholder value.
• Armlogi Holding Corp (NASDAQ:BTOC) gained 24.2% to $0.43 in pre-market trading.
• Neurogene Inc (NASDAQ:NGNE) rose 23.5% to $24.31 in pre-market trading after the company announced that the FDA granted Breakthrough Therapy designation to NGN-401.
• Block Inc (NYSE:XYZ) gained 20.5% to $65.71 in pre-market trading. Block reported in-line earnings for the fourth quarter and announced plans to reduce its workforce by more than 40%.
• Caris Life Sciences Inc (NASDAQ:CAI) surged 17.7% to $22.65 in pre-market trading after the company reported better-than-expected fourth-quarter financial results and announced interim readout of Achieve 1 study.
• MDJM Ltd (NASDAQ:UOKA) gained 17.4% to $0.25 in pre-market trading after jumping 10% on Thursday.
• Dell Technologies Inc (NYSE:DELL) rose 12.4% to $136.54 in pre-market trading as the company reported better-than-expected fourth-quarter financial results and issued FY27 guidance above estimates.

Losers

• Atrium Therapeutics, Inc. (NASDAQ:RNA) fell 86.2% to $10.02 in pre-market trading.
• Avalon GloboCare Corp. (NASDAQ:ALBT) shares dipped 27.2% to $0.7939 in pre-market trading after the company announced up to $9.75 million private placement priced at-the-market under Nasdaq rules.
• Apartment Investment and Management Co (NYSE:AIV) dipped 27.2% to $4.20 in pre-market trading.
• Duolingo Inc (NASDAQ:DUOL) fell 23.2% to $90.19 in pre-market trading after the company reported fourth-quarter financial results and issued FY26 sales guidance below estimates.
• Emergent Biosolutions Inc (NYSE:EBS) fell 21.2% to $8.75 in pre-market trading after the company reported worse-than-expected fourth-quarter financial results and issued FY26 sales guidance below estimates.
• Xponential Fitness Inc (NYSE:XPOF) dipped 20.6% to $6.38 in pre-market trading after the company reported mixed fourth-quarter financial results and issued FY26 sales guidance below estimates.
• Ginkgo Bioworks Holdings Inc (NYSE:DNA) tumbled 16.7% to $8.07 in pre-market trading after the company reported worse-than-expected quarterly financial results.
• Willdan Group, Inc (NASDAQ:WLDN) fell 15.2% to $101.41 in pre-market trading after the company announced fourth-quarter results.
• Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) declined 15.1% to $22.50 in pre-market trading after the company reported worse-than-expected quarterly financial results.
• Ambarella Inc (NASDAQ:AMBA) fell 12.6% to $62.01 in pre-market trading following fourth-quarter results.

Photo via Shutterstock

• No comments yet. Be the first to comment!